Enanta Pharmaceuticals
ENTA
ENTA
120 hedge funds and large institutions have $227M invested in Enanta Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 31 increasing their positions, 43 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.69% more ownership
Funds ownership: 86.15% → 88.83% (+2.7%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
28% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 43
Holders
120
Holding in Top 10
2
Calls
$3.7M
Puts
$870K
Top Buyers
| 1 | +$17M | |
| 2 | +$9.58M | |
| 3 | +$3.59M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.43M |
| 5 |
SC
Stempoint Capital
New York
|
+$900K |
Top Sellers
| 1 | -$6.97M | |
| 2 | -$6.11M | |
| 3 | -$3.58M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.03M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$1.65M |
